Pharmaceutical which obtained European approval in 2009 under the brand name Firdapse, and which licensed the US rights to Catalyst Pharmaceuticals in 2012....

myasthenic syndrome (LEMS). The drug is referred to under the trade name Firdapse, which was approved by the FDA for approved use in children 6 years and...

phosphate salt of 3,4-DAP under the name Firdapse. In 2010, BioMarin was granted exclusive licensing rights to Firdapse for 10 years. As a result, the price...

radiation therapy in those with limited disease. Firdapse is the only FDA-approved treatment for LEMS. Firdapse works in the presynaptic neuromuscular junction...

doi:10.1016/S1474-4422(11)70245-9. PMID 22094130. S2CID 27421424. "LEMS: Firdapse Study Shows Encouraging Results". Muscular Dystrophy Association Press...

Sanders criticized the company's decision to set the annual list price of Firdapse at $375,000, which was previously free, as "a blatant fleecing of American...